GSK plc (GSK.L)

1.450,00 +50,00 (+3,57%) Börsenschluss: 05:18PM BST

GSK plc

980 Great West Road
Brentford TW8 9GS
United Kingdom
44 20 8047 5000
https://www.gsk.com

Sektor(en): Healthcare
Branche: Drug Manufacturers—General
Vollzeitmitarbeiter: 90.096

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Ms. Emma Natasha Walmsley	CEO & Director	3,88M	832,08k	1970
Mr. Iain James Mackay	CFO & Exec. Director	2,88M	N/A	1962
Dr. Hal V. Barron F.A.C.C., M.D.	Chief Scientific Officer, Pres of R&D and Director	6,16M	N/A	1963
Ms. Shobie Ramakrishnan	Chief Digital & Technology Officer	N/A	N/A	N/A
Ms. Sarah Elton-Farr	Head of Investor Relations	N/A	N/A	N/A
Mr. James Ford	Sr. VP & Group Gen. Counsel of Legal & Compliance	N/A	N/A	N/A
Ms. Sally Jackson	Sr. VP of Global Communications & CEO Office	N/A	N/A	N/A
Ms. Diana Conrad	Chief People Officer	N/A	N/A	N/A
Mr. David Simon Redfern	Chief Strategy Officer	N/A	N/A	1966
Mr. Philip C. Thomson	Pres of Global Affairs	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2021 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in GBp.

Beschreibung

GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Corporate Governance

GSK plcs ISS Governance QualityScore, Stand 31. Juli 2022, lautet 5. Die grundlegenden Scores sind Audit: 1, Vorstand: 3, Shareholderrechte: 1, Kompensation: 8.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.